You have 9 free searches left this month | to do more

Talazoparib

Talazoparib is a drug used to treat Breast Cancer, Advanced Solid Tumors, Breast Neoplasms, and other conditions. Talazoparib is being actively studied in 52 studies and prior, has been studied in 13.

Top SponsorsTop SitesTop Investigators
PfizerThe University of Texas MD Anderson Cancer CenterAditya Bardia
National Cancer Institute (NCI)M D Anderson Cancer CenterAtish Choudhury
Dana-Farber Cancer InstituteWashington University School of MedicineBryan Schneider, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +2 more
2022-03-14
Mar 14, 2022
R
Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2022-02-25
Feb 25, 2022
P
Completed
  • Neoplasms
  • talazoparib
  • Changchun, Jilin, China
  • +1 more
2022-01-12
Jan 12, 2022
D
Recruiting
  • Leukemia
  • Talazoparib
  • Boston, Massachusetts
  • +1 more
2021-08-23
Aug 23, 2021
S
Not yet recruiting
  • Acute Myeloid Leukemia
  • Talazoparib
  • +2 more
  • Stanford, California
    Stanford University
2021-10-28
Oct 28, 2021
M
Recruiting
  • Breast Cancer
  • Talazoparib
  • Sacituzumab Govitecan
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-10-25
Oct 25, 2021
T
Recruiting
  • Recurrent Glioma
  • +4 more
  • Talazoparib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
2021-08-19
Aug 19, 2021
M
Active, not recruiting
  • Breast Adenocarcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Talazoparib
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-09
Feb 9, 2022
C
Recruiting
  • Metastatic or Unresectable Melanoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2022-03-22
Mar 22, 2022
D
Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
2021-07-12
Jul 12, 2021
U
Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
2021-10-05
Oct 5, 2021
U
Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2022-03-31
Mar 31, 2022
U
Recruiting
  • HRD 100 Gene Expression High
  • Triple Negative Breast Cancer
  • Talazoparib
  • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
    University Malaya Medical Centre
2022-03-15
Mar 15, 2022
N
Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Cancer Institute LAO
2022-04-07
Apr 7, 2022
M
Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-21
Feb 21, 2022
M
Not yet recruiting
  • Prostate Cancer Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-03-27
Mar 27, 2021
K
Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Indianapolis, Indiana
  • +1 more
2021-09-28
Sep 28, 2021
M
Recruiting
  • Metastatic Prostate Cancer
  • Badalona, Spain
  • +8 more
2022-03-28
Mar 28, 2022
N
Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
2021-08-31
Aug 31, 2021
H
Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
2022-03-14
Mar 14, 2022
K
Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
2022-01-18
Jan 18, 2022
S
Completed
  • Childhood Solid Tumors
  • Talazoparib
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2021-02-08
Feb 8, 2021
N
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
2022-01-25
Jan 25, 2022
Y
Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Talazoparib
  • Placebo
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
2021-02-14
Feb 14, 2021
Z
Active, not recruiting
  • Triple Negative Breast Cancer
  • Gilbert, Arizona
  • +9 more
2022-02-07
Feb 7, 2022